Clifton Park, NY, United States of America

Jeannine Alexander

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Connaught Laboratories Limited. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeannine Alexander. Retrieved from https://idiyas.com/inventor/jeannine-alexander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeannine Alexander: Innovator in Immunological Adjuvants

Introduction

Jeannine Alexander is a notable inventor based in Clifton Park, NY (US). She has made significant contributions to the field of immunology, particularly through her innovative work on vaccine adjuvants. Her research focuses on enhancing immune responses to vaccines, which is crucial for effective immunization.

Latest Patents

Jeannine holds a patent for a Formyl methionyl peptide vaccine adjuvant. This invention relates to immunological adjuvants comprised of the N-formyl methionyl peptide fMLP. The use of fMLP as an adjuvant provides an immune response to suboptimal doses of recombinant antigens, thereby improving vaccine efficacy.

Career Highlights

Jeannine is currently associated with Connaught Laboratories Limited, where she continues her research and development in immunological products. Her work has been instrumental in advancing the understanding of how adjuvants can enhance vaccine performance.

Collaborations

Jeannine collaborates with William I. Cox, who is also involved in the field of immunology. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Jeannine Alexander's contributions to immunological adjuvants highlight her role as a pioneering inventor in the field. Her work not only advances scientific knowledge but also has the potential to improve public health through enhanced vaccine effectiveness.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…